Full-Time

Lead/Staff Bioinformatics Scientist

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$171.8k - $214.8kAnnually

Senior

San Carlos, CA, USA

Hybrid position in San Carlos, Bay Area, California.

Category
Bioinformatics
Biology & Biotech
Required Skills
Python
Linux/Unix
Data Analysis
Requirements
  • PhD in Bioinformatics, Computer Science, Statistics, or related field with a strong focus on cancer epi/genomics
  • Minimum of 6-10 years of experience working in the bioinformatics field, including algorithm development, data analysis, and machine learning
  • Deep understanding of sequencing data
  • Familiar with public databases such as TCGA, COSMIC, or OncoKB
  • Experience in Python
  • Experience using Linux command-line tools and writing shell scripts
  • Ability to visualize findings and summarize results in oral and written form for both technical and non-technical audiences
  • High scientific rigor and eager to teach and learn about new computational methods and biology
Responsibilities
  • Design, implement, and validate innovative algorithms and statistical methods to analyze large-scale data sets related to cancer detection
  • Foster a culture of innovation, collaboration, and scientific excellence
  • Work closely with molecular biologists and clinical scientists to solve challenging problems
  • Contribute to experimental design and ensure data integrity and quality control
  • Act as technical lead during various phases of research and product development
  • Mentor and train other bioinformatics scientists

Natera specializes in genetic testing and diagnostics, focusing on advanced testing solutions for various medical needs. Their main technology is cell-free DNA (cfDNA) testing, which analyzes small DNA fragments in the blood to detect molecular residual disease (MRD) in cancer patients, aiding in treatment decisions. They also offer the Signatera test, a custom ctDNA test for cancer patients, accessible remotely. In addition to oncology, Natera provides testing for organ health in transplant patients and offers tests for women's health, including family planning and prenatal screening. Their Panorama NIPT has conducted over 2 million tests. Natera's business model involves selling testing kits and services to healthcare providers and patients, often reimbursed by insurance, and they provide genetic counseling services for personalized patient support.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

12%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • Growing personalized medicine trend enhances relevance of Natera's custom ctDNA tests.
  • Rise in telehealth services expands reach of Natera's genetic counseling offerings.

What critics are saying

  • Increased competition in cfDNA testing market may impact Natera's market share.
  • Ongoing investigations into alleged deceptive practices could affect investor confidence.
  • Rapid advancements in genetic testing technology risk making current offerings obsolete.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Natera's fetal RhD test addresses RhIg shortages, offering early gestation testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks